Anuh Pharma Ltd.

81.08

-0.1 (-0.1%)growUp

As on February 16, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap811 Cr
P/E Ratio17.16
Dividend Yield0.37 %
Trendline Performance

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open81.17
High81.99
NSE SymbolANUHPHR
Close81.08
Low80.71
BSE Symbol506260
Previous Years High/Low
1 Year High114.9
3 Year High122.85
5 Year High122.85
1 Year Low69.27
3 Year Low69.27
5 Year Low69.27

Technicals


IndicatorsValueSignal
5-DMA82.15Bearish
10-DMA81.37Bearish
20-DMA77.01Bullish
50-DMA77.84Bullish
100-DMA80.15Bullish
200-DMA88.49Bearish

Historical Performance


1 Year
-3.8%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:-0.9
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a moderate PE of 17.16, suggesting fair valuation relative to earnings.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -27.2%, indicating poor shareholder returns.
  • The stock carries a beta of 1.0, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹710 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹6615 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 991137.5
No. of Shares: 12224 (Approx)
Performance:-0.9%
P/L: ₹-8862.5
NIFTY Performance: 11.9%
1 day Top Gainers
SymbolChange%
ENGINERSIN226.62(12%)
NATCOPHARM881.45(7%)
GMRAIRPORT100.52(7%)
RHIM462.25(6%)
AKUMS477.2(6%)
1 Day Top Losers
SymbolChange%
FIRSTCRY239.7(-11%)
BSE2804.6(-7%)
OLAELEC28.83(-7%)
MAPMYINDIA1152.7(-7%)
TBOTEK1442.3(-5%)
INOXWIND101.19(-5%)
ANGELONE2572.8(-5%)
MANYAVAR435.85(-4%)

Top Performing Stocks from the same sector


NGL Fine-Chem Ltd.

53.8%

2289.4

1 Month Performance

Lincoln Pharmaceuticals Ltd.

30.1%

623.55

1 Month Performance

Ind-Swift Laboratories Ltd.

29.6%

143.74

1 Month Performance

Bliss GVS Pharma Ltd.

29%

221.97

1 Month Performance

Ortin Global Ltd.

22.6%

16.39

1 Month Performance

Acutaas Chemicals Ltd.

20%

2039.2

1 Month Performance

Rubicon Research Ltd.

17.5%

793.85

1 Month Performance

Wanbury Ltd.

16.8%

252.8

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month